PT97912A - Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem - Google Patents

Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT97912A
PT97912A PT97912A PT9791291A PT97912A PT 97912 A PT97912 A PT 97912A PT 97912 A PT97912 A PT 97912A PT 9791291 A PT9791291 A PT 9791291A PT 97912 A PT97912 A PT 97912A
Authority
PT
Portugal
Prior art keywords
aliphatic
compound
aryl
alkyl
process according
Prior art date
Application number
PT97912A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert A Daines
William Dennis Kingsbury
Israil Nmi Pendrak
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PT97912A publication Critical patent/PT97912A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97912A 1990-06-07 1991-06-07 Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem PT97912A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
PT97912A true PT97912A (pt) 1992-03-31

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97912A PT97912A (pt) 1990-06-07 1991-06-07 Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem

Country Status (16)

Country Link
EP (1) EP0532550A1 (fr)
JP (1) JPH05507475A (fr)
KR (1) KR930700445A (fr)
CN (1) CN1058016A (fr)
AU (1) AU7901791A (fr)
CA (1) CA2083958A1 (fr)
FI (1) FI925544L (fr)
HU (1) HUT64748A (fr)
IE (2) IE911913A1 (fr)
IL (1) IL98388A0 (fr)
MA (1) MA22196A1 (fr)
MX (1) MX26142A (fr)
PL (1) PL290586A1 (fr)
PT (1) PT97912A (fr)
WO (1) WO1991018880A1 (fr)
ZA (1) ZA914323B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022285A1 (fr) * 1992-05-01 1993-11-11 Smithkline Beecham Corporation Antagonistes de leucotrienes
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
EP0649408A4 (fr) 1992-06-30 1995-06-21 Smithkline Beecham Corp Procede de production de phenylthiomethylpyridinylalcenoates.
EP0675718A1 (fr) * 1992-12-23 1995-10-11 Smithkline Beecham Corporation Composes de pyridyle a substitution utiles comme antagonistes des leucotrienes
EP0733044A4 (fr) * 1993-12-08 1997-03-05 Smithkline Beecham Corp Composes
WO1995028386A1 (fr) * 1994-04-13 1995-10-26 F. Hoffmann-La Roche Ag Antagonistes des leucotrienes b4 a substitution pyridine
CN100456944C (zh) * 2001-03-27 2009-02-04 明治制果株式会社 膨化小食品的制造方法及其制造装置
DK2520654T3 (en) 2003-08-26 2017-05-01 Univ Colorado Regents Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
AU7901791A (en) 1991-12-31
HUT64748A (en) 1994-02-28
HU9203866D0 (en) 1993-03-29
JPH05507475A (ja) 1993-10-28
WO1991018880A1 (fr) 1991-12-12
KR930700445A (ko) 1993-03-15
MA22196A1 (fr) 1992-04-01
FI925544A0 (fi) 1992-12-07
PL290586A1 (en) 1992-04-06
IL98388A0 (en) 1992-07-15
CA2083958A1 (fr) 1991-12-08
FI925544A7 (fi) 1992-12-07
IE911912A1 (en) 1991-12-18
FI925544L (fi) 1992-12-07
ZA914323B (en) 1992-06-24
EP0532550A1 (fr) 1993-03-24
MX26142A (es) 1994-02-28
IE911913A1 (en) 1991-12-18
CN1058016A (zh) 1992-01-22

Similar Documents

Publication Publication Date Title
JPS63246372A (ja) ３−ヘテロ置換−ｎ−ベンジル−インドール
JP2006528218A (ja) Ｇｆａｔインヒビター
RS51005B (sr) Analozi lipoksina a4
JPS61148150A (ja) アミノフエノ−ル誘導体
US5286736A (en) Pyridyl compounds and pharmaceutical compositions containing these compounds
JPS61218570A (ja) 新規複素環アミド化合物、およびそれらを含有する医薬組成物
PT97913A (pt) Processo de preparacao de derivados do acido benzoico e de composicoes farmaceuticas que os contem
US4694018A (en) Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
US4959364A (en) Method of treating inflammation, allergy, asthma and proliferative skin disease using heterocyclic amides
CA2083958A1 (fr) Derives d'acide benzoique pour le traitement de maladies associees aux leucotrienes
JPH0597839A (ja) ホスホリパーゼａ２阻害剤としてのテトロン酸誘導体およびチオテトロン酸誘導体
US4663333A (en) Acylaminoalkylpyridines ad use in treatment of inflammation and allergy reactions
PT97911A (pt) Processo de preparacao de derivados de acidos piridilbenzoicos ligados a amida e de composicoes farmaceuticas
Yang et al. Discovery of cloxiquine derivatives as potent HDAC inhibitors for the treatment of melanoma via activating PPARγ
US5508309A (en) LTB4 synthesis inhibitors
JPH0649677B2 (ja) テトラヒドロナフタレン誘導体、その製法並びにその合成中間体
US5656636A (en) Pyridine compounds for treating leukotriene-related diseases
EP0532634A1 (fr) Derives d'acide phtalamique utilises dans le traitement de maladies associees aux leucotrienes
JP2840337B2 (ja) 腫瘍転移抑制剤
PT98974A (pt) Processo de preparacao de derivados de acidos piridiltio ou piridiloxi-alcanoicos e de composicoes farmaceuticas que os contem
DE19823722A1 (de) Chinolinylmethoxyaryl-Verbindungen als duale Inhibitoren der Cyclooxygenase und 5-Lipoxygenase
TW591023B (en) Excitatory amino acid receptor antagonists
JPH09506367A (ja) 化合物
JP2004520335A5 (fr)
EP0639975A1 (fr) Composes de pyridine heterocyclique substituee et leurs utilisations

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911115

FC3A Refusal

Effective date: 19980722